Sudarshan Pharma Industries Limited (BOM:543828)
India
· Delayed Price · Currency is INR 24.91
-0.38 (-1.50%)
At close: Mar 9, 2026
BOM:543828 Revenue
Sudarshan Pharma Industries had revenue of 1.68B INR in the quarter ending December 31, 2025, with 45.26% growth. This brings the company's revenue in the last twelve months to 6.44B, up 40.15% year-over-year. In the fiscal year ending March 31, 2025, Sudarshan Pharma Industries had annual revenue of 5.05B with 8.95% growth.
Revenue (ttm)
6.44B
Revenue Growth
+40.15%
P/S Ratio
0.93
Revenue / Employee
107.29M
Employees
60
Market Cap
5.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.05B | 415.07M | 8.95% |
| Mar 31, 2024 | 4.64B | 22.10M | 0.48% |
| Mar 31, 2023 | 4.61B | 1.04B | 29.19% |
| Mar 31, 2022 | 3.57B | 1.64B | 84.52% |
| Mar 31, 2021 | 1.94B | 455.35M | 30.77% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kopran | 6.20B |
| Kilitch Drugs (India) | 2.07B |
| Bharat Parenterals | 3.50B |
| Fredun Pharmaceuticals | 5.91B |
| Anuh Pharma | 7.68B |
| Jenburkt Pharmaceuticals | 1.65B |
| Wanbury | 6.58B |
| Albert David | 3.23B |